UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2013, Volume 2013, Issue 12, pp. CD008846 - CD008846
Disease Eradication | Malaria | Mosquito control | Antimalarials | Drugs for prevention for people living in endemic areas | Combined treatment, artemisinin based | Treatment of uncomplicated falciparum malaria | Treating uncomplicated malaria | Endemic Diseases | Prevention | Delivery strategies | Infectious disease | Blood disorders | Treatment | Malaria: treating uncomplicated disease | Child health | Program Evaluation | Parasitemia | Medicine General & Introductory Medical Sciences | Malaria: prevention | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antimalarials - adverse effects | Antimalarials - administration & dosage | Humans | Parasitemia - drug therapy | Disease Eradication - methods | Malaria - drug therapy | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2013, Volume 4, Issue 4, pp. 502 - 530
Aprepitant | Cytokines | Ketoconazole | Captopril | Glioblastoma | Sertraline | Neurokinin | Artesunate | Angiotensin | Nelfinavir | Disulfiram | Temozolomide | Auranofin | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Dacarbazine - administration & dosage | Ketoconazole - administration & dosage | Humans | Morpholines - administration & dosage | Artemisinins - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Brain Neoplasms - drug therapy | Captopril - administration & dosage | Gluconates - administration & dosage | Succinates - administration & dosage | Sertraline - administration & dosage | Auranofin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Dacarbazine - analogs & derivatives | Glioblastoma - drug therapy | Nelfinavir - administration & dosage | Disulfiram - administration & dosage | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prevalence | State Medicine | Artemether, Lumefantrine Drug Combination | Humans | Fluorenes - therapeutic use | Male | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Incidence | Rural Population | Malaria, Falciparum - diagnosis | Malaria, Falciparum - epidemiology | Female | Fluorenes - administration & dosage | Drug Resistance | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Mass Drug Administration - methods | Primaquine - therapeutic use | Myanmar - epidemiology | Ethanolamines - therapeutic use | Early Diagnosis | Drug Combinations | Plasmodium falciparum | Diagnosis | Malaria | Analysis | Intervention | Dihydroartemisinin | Vector-borne diseases | Medical research | Primaquine | Hot spots | Artemisinin | Parasites | Dosage | Medical diagnosis | Molecular chains | Surveys | Charities | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Villages | Artemether | Histocompatibility antigen HLA | Adults | Diagnostic systems | Genotypes | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article